Innoviva (INVA) Gross Margin (2011 - 2026)
Innoviva's Gross Margin was 75.77% in Q2 2026, down 7.14 percentage points from 82.91% a year earlier and down 1.61 percentage points from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Gross Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Innoviva's Gross Margin was 72.19% through Jun 30, 2026, down 10.89 percentage points year-over-year; for FY2025, it came in at 74.80%, down 7.78 percentage points from FY2024.
- Gross Margin shows a five-year change of -25.20 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 82.58% in FY2024 (+3.33 pp), 79.25% in FY2023 (-16.59 pp), 95.84% in FY2022 (-4.16 pp) and 100.00% in FY2021 (unchanged).
- Quarterly Gross Margin has moved between 66.02% (Q4 2025) and 100.00% (Q2 2022) over five years.
- Compared with a year earlier, Gross Margin has declined for five straight quarters, with an average year-over-year change of -6.67 percentage points over the last six quarters.
- The best year-over-year quarter for Gross Margin over five years was Q1 2025 (a gain of 5.18 percentage points); the worst was Q4 2025 (a drop of 19.08 percentage points).
- Per Business Quant data, INVA's Gross Margin in the three quarters before Q2 2026 was 77.39% (Q1 2026), 66.02% (Q4 2025) and 70.07% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Innoviva | 1.54 Bn | -750.13 Mn | 90.62 Mn | 75.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.77% |
| Mar 31, 2026 | 77.39% |
| Dec 31, 2025 | 66.02% |
| Sep 30, 2025 | 70.07% |
| Jun 30, 2025 | 82.91% |
| Mar 31, 2025 | 82.72% |
| Dec 31, 2024 | 85.10% |
| Sep 30, 2024 | 81.56% |
| Jun 30, 2024 | 85.07% |
| Mar 31, 2024 | 77.53% |
| Sep 30, 2023 | 84.86% |
| Jun 30, 2023 | 88.91% |
| Mar 31, 2023 | 88.54% |
| Sep 30, 2022 | 94.53% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |
| Mar 31, 2014 | 75.90% |
| Mar 31, 2013 | 100.00% |
API Access
Innoviva Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();